“…Notably, RGC markers had the highest downregulation fold changes, as for example, peripherin (-12.7x), neurofilament heavy, medium and light polypeptides (-11.4x, -11.8x and -6.8x, respectively), gamma synuclein (-10.8x), POU class 4 homeobox 2 (or Brn3A, -7.3x), Thy-1 cell surface antigen (-3.9x), synaptotagmin II (-2.4x), tubulin, beta 3 class III (-1.9x), internexin neuronal intermediate filament protein (-1.9x), alpha-internexin (-1.9x) and pannexin 2 (-1.89x). In addition, the retinal ganglion cell neurotrophic factor neuritin 1 [59] was also strongly down-regulated after ONC, with a -18.8x decrease when compared to controls ( Figure 2B). The EnrichR software, a tool to determine disease-enriched perturbations in the transcriptome that uses the GEO database, showed that among the down-regulated genes at 14 days after ONC, the top disease signature was "Glaucoma associated with systemic syndromes" (Table S4).…”